To include your compound in the COVID-19 Resource Center, submit it here.

Ezutromid: Phase II started

Summit began the 48-week, open-label, international Phase II PhaseOut DMD trial

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE